切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2007, Vol. 01 ›› Issue (01) : 5 -8. doi: 10.3877/cma.j.issn.1674-0807.2007.01.003

专家论坛

乳腺癌前哨淋巴结活检研究进展
王永胜1   
  1. 1.250117 济南,山东省肿瘤医院乳腺病中心
  • 收稿日期:2006-09-07 出版日期:2007-01-25

Advancement of sentinel lymph node in breast cancer

Yong-sheng Wang   

  • Received:2006-09-07 Published:2007-01-25
引用本文:

王永胜. 乳腺癌前哨淋巴结活检研究进展[J/OL]. 中华乳腺病杂志(电子版), 2007, 01(01): 5-8.

Yong-sheng Wang. Advancement of sentinel lymph node in breast cancer[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(01): 5-8.

[1]
Fleissig A, Fallowfield L J,Langridge C I,etal.Postoperative arm morbidity and quality of life.Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer[J].Breast Cancer Res Treat,2006,95(3) :279 -293.
[2]
Veronesi U, Paganelli G, Viale G,etal.A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[J].N Engl J Med,2003,349(6) :546 -553.
[3]
Julian TB, Krag D, Brown A,etal.Preliminary technical results of NSAPBP B-32, a randomized phase Ⅲclinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients[J].Breast Cancer Res Treat,2004,88(sl) :sl1 -12.
[4]
Goyal A, Newcombe R G, Mansel R E,etal.Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer[J].Eur J Cancer,2005,41(2) :238 -243.
[5]
Barone J E, Tucker J B, Perez J M.Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer[J].Am Surg,2005,71(1):66 -70.
[6]
Martin R C,Chagpar A, Scoggins C R,etal.Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer[J].Ann Surg,2005,241(6) :1005 -1015.
[7]
Galimberti V.How safe is a sentinel node biopsy[J]?Eur J Cancer,2006,4(2) :114.
[8]
Veronesi U, Galimberti V, Mariani L, etal.Sentinel node biopsy in breast cancer:early results in 953 patients with negative sentinel node biopsy and no axillary dissection[J].Eur J Cancer,2005,41(2):231-237.
[9]
Palesty J A, Foster J M, Hurd T C,etal.Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer[J].J Surg Oncol,2006,93(2) :129 -132.
[10]
王永胜,左文述,刘娟娟,等.乳腺癌前哨淋巴结活检替代腋窝清扫术前瞻性非随机对照临床研究[J].外科理论与实践,2006,11(2):104-107.
[11]
van Rijk M C, Nieweg O E, Valds Olmos R A,etal.Non-axillary breast cancer recurrences after sentinel node biopsy[J].J Surg Oncol,2005,92(4):292 -298.
[12]
Halverson K J, Taylor M E, Perez C A, etal.Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage Ⅰ and Ⅱ breast cancer[J].Int J Radiat Oncol Biol Phys,1993,26(4):593-599.
[13]
Edge S B, Niland J C, Bookman M A, etal.Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers[J].J Natl Cancer Inst,2003,95(20):1514 -1521.
[14]
Mansel R E, Fallowfield L, Kissin M,etal.Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer:the ALMANAC Trial[J].J Natl Cancer Inst,2006,98(9) :599 -609.
[15]
Purushotham A D, Upponi S, Klevesath M B, etal.Morbidity after sentinel lymph node biopsy in primary breast cancer:results from a randomized controlled trial[J].J Clin Oncol,2005,23(19):4312-4321.
[16]
Schulze T, Mucke J, Markwardt J, etal.Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection[J].J Surg Oncol,2006,93(2):109-119.
[17]
Rietman J S,Geertzen J H, Hoekstra H J,etal.Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage Ⅰ or Ⅱbreast cancer[J].Eur J Surg Oncol,2006,32(2):148 - 152.
[18]
Martin R C,Chagpar A, Scoggins C R,etal.University of Louisville Breast Cancer Sentinel Lymph Node Study.Clinicopathologic factors associated with falsenegative sentinel lymph-node biopsy in breast cancer[J].Ann Surg,2005,241(6):1005-1015.
[19]
Degnim A C,Oh K,Cimmino V M,etal.Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram[J]?Ann Surg Oncol,2005,12(9) :712-717.
[20]
Cremonesi M, Ferrari M, Sacco E, etal.Radiation protection in radioguided surgery of breast cancer[J].Nucl Med Commun, 1999, 20(10) :919 -924.
[21]
Klausen T L, Chakera A H, Friis E,etal.Radiation doses to staff involved in sentinel node operations for breast cancer[J].Clin Physiol Funct Imaging,2005,25(4) :196 -202.
[22]
Nejc D,Wrzesie M, Piekarski J,etal.Sentinel node biopsy in patients with breast cancer—evaluation of exposure to radiation of medical staff[J].Eur J Surg Oncol,2006,32(2) :133 -138.
[23]
Specht M C, Fey J V, Borgen P I,etal.Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy[J]? J Am Coll Surg,2005,200(1) :10-14.
[24]
Knauer M, Konstantiniuk P, Haid A, etal.Multicentric breast cancer:a new indication for sentinel node biopsy—a multi-institutiona l validation study[J].J Clin Oncol,2006,24(21):3374-3380.
[25]
Tousimis E, Van Zee K J, Fey J V,etal.The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers[J].J Am Coll Surg,2003,197(4):529-535.
[26]
Kumar R, Jana S, Heiba S,etal.Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable or nonpalpable breast cancer[J].J Nucl Med,2002,44(1) :7 -10.
[27]
Haigh P, Hansen N, Qi K,etal.Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast can cer[J].Ann Surg Oncol,2000,7(1):21-27.
[28]
Wong S L, Edwards M J, Chao C,etal.The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy[J].Ann Surg Oncol,2002,9(3) :272 - 277.
[29]
Luini A, Galimberti V, Gatti G, etal.The sentinel node biopsy after previous breast surgery:preliminary results on 543 patients treated at the European Institute of Oncology[J].Breast Cancer Res Treat, 2005,89(2) :159 -163.
[30]
van Rijk M C, Nieweg O E, Rutgers E J,etal.Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection[J].Ann Surg Oncol,2006,13(4) :475 -479.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[3] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[4] 张启龙, 柳亿, 卢会丽, 罗慧, 李成林, 王菁, 王辉. 奥妥珠单抗治疗磷脂酶A2受体相关膜性肾病的疗效与安全性:单中心回顾性分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 379-384.
[5] 王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[6] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[7] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[8] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[9] 王浩源, 汪海洋, 孙建明, 陈以宽, 祁小桐, 唐博. 腹腔镜与开放修补对肝硬化腹外疝患者肝功能及凝血的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 654-659.
[10] 王鹏, 邵欣欣, 胡海涛, 田艳涛, 钟宇新. 改良MOBS 吻合法在全腹腔镜近端胃大部分切除中的应用[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 267-270.
[11] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[12] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要